Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies

por Shen, Chunyi, Zhang, Zhen, Zhang, Yi
Publicado 2020

Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity

por Ping, Yu, Shen, Chunyi, Huang, Bo, Zhang, Yi
Publicado 2022

Mechanism and strategies of immunotherapy resistance in colorectal cancer

por Shan, Jiqi, Han, Dong, Shen, Chunyi, Lei, Qingyang, Zhang, Yi
Publicado 2022

Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma

por Zheng, Yujia, Liu, Yulin, Zhao, Songfeng, Zheng, Zhetian, Shen, Chunyi, An, Li, Yuan, Yongliang
Publicado 2018

LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance

por Zhang, Boya, Zhang, Mingpeng, Shen, Chunyi, Liu, Guancong, Zhang, Fan, Hou, Jingyu, Yao, Weitao
Publicado 2021

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway

por Shen, Chunyi, Zhang, Zhen, Tian, Yonggui, Li, Feng, Zhou, Lingxiao, Jiang, Wenyi, Yang, Li, Zhang, Bin, Wang, Liping, Zhang, Yi
Publicado 2021

PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer

por Shen, Chunyi, Liu, Chaojun, Zhang, Zhen, Ping, Yu, Shao, Jingwen, Tian, Yonggui, Yu, Weina, Qin, Guohui, Liu, Shasha, Wang, Liping, Zhang, Yi
Publicado 2021

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma

por Zhang, Qingyi, Zhao, Xuan, Zhang, Chaoqi, Wang, Wei, Li, Feng, Liu, Donglei, Wu, Kai, Zhu, Dengyan, Liu, Shasha, Shen, Chunyi, Yuan, Xin, Zhang, Kai, Yang, Yang, Zhang, Yi, Zhao, Song
Publicado 2019